Skip to main content
TipRanks
Go Ultimate75% OFF

Turn Therapeutics Inc (TTRX) Stock Statistics & Valuation Metrics

30 Followers

Total Valuation

Turn Therapeutics Inc has a market cap or net worth of $264.15M. The enterprise value is $429.54M.

Market Cap
$264.15M
Enterprise Value
$429.54M

Share Statistics

Turn Therapeutics Inc has 30,572,704 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
30,572,704
Owned by Insiders
59.05%
Owned by Institutions
1.05%

Financial Efficiency

Turn Therapeutics Inc’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -94.42%.

Return on Equity (ROE)
-0.68
Return on Assets (ROA)
-0.26
Return on Invested Capital (ROIC)
-94.42%
Return on Capital Employed (ROCE)
-0.95
Revenue Per Employee
0
Profits Per Employee
-1.60M
Employee Count
2
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Turn Therapeutics Inc is -18.68. Turn Therapeutics Inc’s PEG ratio is 0.23.

PE Ratio
-18.68
PS Ratio
0.00
PB Ratio
42.86
Price to FCF
-46.86
Price to Operating Cash Flow
-46.19
PEG Ratio
0.23

Income Statement

In the last 12 months, Turn Therapeutics Inc had revenue of 0 and earned -3.19M in profits. Earnings per share was -0.23.

Revenue
0
Gross Profit
0
Operating Income
-5.86M
Pretax Income
-3.19M
Net Income
-3.19M
EBITDA
-3.14M
Earnings Per Share (EPS)
-0.23

Cash Flow

In the last 12 months, operating cash flow was -5.28M and capital expenditures -2, giving a free cash flow of -5.28M billion.

Operating Cash Flow
-5.28M
Free Cash Flow
-5.28M
Free Cash Flow per Share
-0.18

Dividends & Yields

Turn Therapeutics Inc pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.16%
Earnings Yield
-5.29%

Stock Price Statistics

Beta
0.92
52-Week Price Change
198.71%
50-Day Moving Average
11.51
200-Day Moving Average
7.36
Relative Strength Index (RSI)
34.98
Average Volume (3m)
119.01K

Important Dates

Turn Therapeutics Inc upcoming earnings date is Apr 06, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 09, 2026
Next Earnings Date
Apr 06, 2027
Ex-Dividend Date
―

Financial Position

Turn Therapeutics Inc as a current ratio of 0.87, with Debt / Equity ratio of 1.71%

Current Ratio
0.87
Quick Ratio
0.87
Debt to Market Cap
0.00
Net Debt to EBITDA
1.59
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Turn Therapeutics Inc has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Turn Therapeutics Inc EV to EBITDA ratio is -55.15, with an EV/FCF ratio of -44.49.

EV to Sales
0.00
EV to EBITDA
-55.15
EV to Free Cash Flow
-44.49
EV to Operating Cash Flow
-44.49

Balance Sheet

Turn Therapeutics Inc has $10.36M in cash and marketable securities with $490.55K in debt, giving a net cash position of $9.87M billion.

Cash & Marketable Securities
$10.36M
Total Debt
$490.55K
Net Cash
$9.87M
Net Cash Per Share
$0.32
Tangible Book Value Per Share
$0.16

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Turn Therapeutics Inc is $17.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$17.00
Price Target Upside
110.01% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
―
EPS Growth Forecast
―

Scores

Smart Score
6
AI Score
47